Mar 6, 2026 02:19PM
Mar 5, 2026 06:52AM
Mar 4, 2026 02:56PM
Mar 4, 2026 07:03AM
Feb 17, 2026 12:57PM
Feb 5, 2026 08:54AM
Feb 2, 2026 08:39AM Mizuho on EyePoint Inc. (EYPT): 'Competitor P3 Data Coming, So Expect Volatility; Recent Weakness Provides an Opportunity'
Jan 7, 2026 09:55AM
Jan 7, 2026 09:02AM
Jan 7, 2026 07:03AM
Jan 2, 2026 10:00PM
Dec 21, 2025 08:00PM
Dec 9, 2025 10:49AM
Dec 8, 2025 09:55AM EyePoint Pharmaceuticals (EYPT) Changes Names to Eyepoint Inc - SEC
Nov 20, 2025 06:41AM
Nov 5, 2025 07:05AM
Oct 20, 2025 06:55AM
Oct 14, 2025 04:24PM
Oct 2, 2025 06:38AM
Aug 14, 2025 01:52PM
Aug 6, 2025 07:03AM EyePoint Pharmaceuticals (EYPT) Misses Q2 EPS by 4c
May 30, 2025 06:44AM
May 27, 2025 12:20PM
May 16, 2025 05:35AM
May 7, 2025 07:06AM
Mar 17, 2025 10:33AM
Mar 17, 2025 10:00AM
Mar 6, 2025 07:24AM H.C. Wainwright Reiterates Buy Rating on EyePoint Pharmaceuticals, Inc. (EYPT)
Mar 5, 2025 07:04AM
Feb 5, 2025 10:19AM
Feb 5, 2025 08:23AM
Feb 5, 2025 07:01AM
Jan 13, 2025 07:07AM
Jan 8, 2025 07:02AM
Jan 7, 2025 05:01AM Citi Starts EyePoint Pharmaceuticals, Inc. (EYPT) at Buy
Dec 4, 2024 07:03AM
Nov 11, 2024 08:40AM
Nov 11, 2024 07:24AM
Nov 7, 2024 05:14PM
Oct 30, 2024 06:07AM
Oct 28, 2024 05:14PM
Oct 28, 2024 02:23PM Guggenheim Reiterates Buy Rating on EyePoint Pharmaceuticals, Inc. (EYPT)
Oct 28, 2024 10:59AM
Oct 28, 2024 07:00AM
Oct 25, 2024 08:06AM
Oct 25, 2024 05:52AM
Oct 24, 2024 02:34PM
Oct 24, 2024 07:02AM
Sep 4, 2024 07:01AM EyePoint Pharmaceuticals (EYPT) Appoints Fred Hassan to its Board
Aug 28, 2024 02:16AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All